BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

680 related articles for article (PubMed ID: 1692536)

  • 21. Recombinant human stem cell factor synergises with GM-CSF, G-CSF, IL-3 and epo to stimulate human progenitor cells of the myeloid and erythroid lineages.
    McNiece IK; Langley KE; Zsebo KM
    Exp Hematol; 1991 Mar; 19(3):226-31. PubMed ID: 1704845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant murine granulocyte-macrophage (GM) colony-stimulating factor supports formation of GM and multipotential blast cell colonies in culture: comparison with the effects of interleukin-3.
    Koike K; Ogawa M; Ihle JN; Miyake T; Shimizu T; Miyajima A; Yokota T; Arai K
    J Cell Physiol; 1987 Jun; 131(3):458-64. PubMed ID: 3298286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo and in vitro interaction between interleukin 6 and granulocyte colony-stimulating factor in the regulation of murine hematopoiesis.
    Pojda Z; Tanaka K; Aoki Y; Tsuboi A
    Exp Hematol; 1992 Aug; 20(7):874-8. PubMed ID: 1378408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth-inhibitory effect of 2-CdA on myeloid CFU-GM progenitors in normal human long-term bone marrow cultures and its compensation by G-CSF or IL-3.
    Petzer AL; Geisen FH; Bilgeri R; Zilian U; Haun M; Herold M; Braunsteiner H; Konwalinka G
    Exp Hematol; 1995 Jun; 23(6):529-34. PubMed ID: 7539380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stimulation of canine hematopoiesis by recombinant human granulocyte-macrophage colony-stimulating factor.
    Schuening FG; Storb R; Goehle S; Nash R; Graham TC; Appelbaum FR; Hackman R; Sandmaier BM; Urdal DL
    Exp Hematol; 1989 Sep; 17(8):889-94. PubMed ID: 2670596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growth characteristics of marrow hematopoietic progenitor/precursor cells from patients on a phase I clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factor.
    Broxmeyer HE; Cooper S; Williams DE; Hangoc G; Gutterman JU; Vadhan-Raj S
    Exp Hematol; 1988 Aug; 16(7):594-602. PubMed ID: 3260558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short-term in vivo priming of bone marrow haematopoiesis with rhG-CSF, rhGM-CSF or rhIL-3 before marrow harvest expands myelopoiesis but does not improve engraftment capability.
    Hansen PB; Knudsen H; Gaarsdal E; Jensen L; Ralfkiaer E; Johnsen HE
    Bone Marrow Transplant; 1995 Sep; 16(3):373-9. PubMed ID: 8535309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro and in vivo activity of human recombinant granulocyte-macrophage colony-stimulating factor in dogs.
    Mayer P; Werner FJ; Lam C; Besemer J
    Exp Hematol; 1990 Oct; 18(9):1026-33. PubMed ID: 2168838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergistic effects of purified recombinant human and murine B cell growth factor-1/IL-4 on colony formation in vitro by hematopoietic progenitor cells. Multiple actions.
    Broxmeyer HE; Lu L; Cooper S; Tushinski R; Mochizuki D; Rubin BY; Gillis S; Williams DE
    J Immunol; 1988 Dec; 141(11):3852-62. PubMed ID: 3053902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of recombinant granulocyte colony-stimulating factor (rG-CSF) and recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF) on acute radiation hematopoietic injury in mice.
    Tanikawa S; Nakao I; Tsuneoka K; Nara N
    Exp Hematol; 1989 Sep; 17(8):883-8. PubMed ID: 2475360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergistic effects between GM-CSF and G-CSF or M-CSF on highly enriched human marrow progenitor cells.
    Bot FJ; van Eijk L; Schipper P; Backx B; Löwenberg B
    Leukemia; 1990 May; 4(5):325-8. PubMed ID: 1697008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced myelopoiesis in long-term cultures of human bone marrow pretreated with recombinant granulocyte-macrophage colony-stimulating factor.
    Haas R; Ogniben E; Kiesel S; Hohaus S; Baumann M; Körbling M; Dörken B; Hunstein W
    Exp Hematol; 1989 Mar; 17(3):235-9. PubMed ID: 2645156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin-6 is a survival factor for committed myeloid progenitor cells.
    Kerst JM; Slaper-Cortenbach IC; van der Schoot CE; Hooibrink B; von dem Borne AE; van Oers RH
    Exp Hematol; 1993 Nov; 21(12):1550-7. PubMed ID: 7691639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of recombinant human granulocyte colony-stimulating factor administration in normal and experimentally infected newborn rats.
    Iguchi K; Inoue S; Kumar A
    Exp Hematol; 1991 Jun; 19(5):352-8. PubMed ID: 1709109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) on single CD34-positive hemopoietic progenitors from human bone marrow.
    Mayani H; Baines P; Jones A; Hoy T; Jacobs A
    Int J Cell Cloning; 1989 Jan; 7(1):30-6. PubMed ID: 2645375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abnormal responses of myeloid progenitor cells to granulocyte-macrophage colony-stimulating factor in human cyclic neutropenia.
    Wright DG; LaRussa VF; Salvado AJ; Knight RD
    J Clin Invest; 1989 Apr; 83(4):1414-8. PubMed ID: 2649515
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thrombopoiesis-stimulating factor: its effects on megakaryocyte colony formation in vitro and its relation to human granulocyte-macrophage colony-stimulating factor.
    Dessypris EN; Chuncharunee S; Frierson KE
    Exp Hematol; 1990 Aug; 18(7):754-7. PubMed ID: 2199204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AM5, a protein-associated polysaccharide, stimulates hematopoiesis and modulates the expression of endogenous hematopoietic growth factors in murine long-term bone marrow cultures.
    Güenechea G; Bueren JA; Maganto G; Tuduri P; Guerrero A; Pivel JP; Real A
    Stem Cells; 1995 Mar; 13(2):175-85. PubMed ID: 7540471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro study of erythropoiesis in patients with aplastic anemia and myelodysplastic syndromes: a possible tool for prospective determination of the clinical effectiveness of growth factors.
    Aoki A; Shibata A
    Hematol Pathol; 1992; 6(3):143-53. PubMed ID: 1429342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of the primitive megakaryocyte progenitors (BFU-meg) in adult human peripheral blood.
    Zauli G; Vitale L; Brunelli MA; Bagnara GP
    Exp Hematol; 1992 Aug; 20(7):850-4. PubMed ID: 1378407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.